Mylan Pharmaceuticals Private Limited clinical trials
Acquired by Viatris Inc., Nov 16, 2020 · source ↗
The registry lists 1 studies whose lead sponsor is Mylan Pharmaceuticals Private Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 3, 2022.
Before and after it joined Viatris Inc.
- First submitted before Mylan Pharmaceuticals Private Limited became part of Viatris Inc.
- 1
- First submitted after Mylan Pharmaceuticals Private Limited became part of Viatris Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Mylan Pharmaceuticals Private Limited1 study
Something wrong with this grouping? Tell us on the Viatris Inc. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Viatris Inc. studies →
- A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"CompletedNCT03172780Phase 3
Sponsor listed in the registry: Mylan Pharmaceuticals Private Limited · First submitted before Mylan Pharmaceuticals Private Limited became part of Viatris Inc.